The FDA has been without a permanent leader since President Biden took office.
WASHINGTON - White House is considering to appoint Dr. Robert M. Califf, former Commissioner of the Food and Drug Administration, to lead the agency again, according to five people familiar with the search for a candidate.
The FDA was without a permanent leader since President Biden took office , which has led to frequent criticismques from public health experts who said the agency lacks clear direction during an intense phase of the pandemic, as it faced a crash of vaccine reviews, testing and treatments for the coronavirus.
People familiar with the research process said no final decision has been made. The F.D.A. Acting Commissioner, Dr Janet Woodcock, a longtime drug regulator, nears the end of the term that interim officials are allowed to serve.
Dr. Califf declined to comment. News of his possible appointment was first reported by the Washington Post.
Dr. Califf, a cardiologist who teaches at Duke University School of Medicine, served only briefly as an F.D.A. Commissioner, at the end of President Barac's second termk Obama. He was deputy commissioner of the ioner medical products and tobacco agency before leading it from February 2016 to January 2017.
He was confirmed by the Senate as commissioner in February 2016 in a vote of 89: 4, after some lawmakers opposed his appointment over what they called the agency 's poor record in preion pain relievers. His appointment faced its fiercest resistance from Democrats.
Katie Rogers, Sharon LaFraniere and Katie Thomas contributed to the reports.